A novel definition of cardiac allograft vasculopathy

H. J. Eisen

doi:10.1111/j.1600-6143.2012.04240.x

A novel definition of cardiac allograft vasculopathy

H. J. Eisen

Research output: Contribution to journal › Editorial › peer-review

Abstract

The author reviews the article by Arora and colleagues (page 2700) and puts into context the observations made regarding the use of everolimus in patients several years out from transplant with established cardiac allograft vasculopathy, as well as the utility of the novel imaging technique, virtual histology, used in the study.

Original language	English (US)
Pages (from-to)	2571-2572
Number of pages	2
Journal	American Journal of Transplantation
Volume	12
Issue number	10
DOIs	https://doi.org/10.1111/j.1600-6143.2012.04240.x
State	Published - Oct 2012

All Science Journal Classification (ASJC) codes

Immunology and Allergy
Transplantation
Pharmacology (medical)

Access to Document

10.1111/j.1600-6143.2012.04240.x

Cite this

@article{b5f4b1ec8fa24396b3958c92b0cdcf38,

title = "A novel definition of cardiac allograft vasculopathy",

abstract = "The author reviews the article by Arora and colleagues (page 2700) and puts into context the observations made regarding the use of everolimus in patients several years out from transplant with established cardiac allograft vasculopathy, as well as the utility of the novel imaging technique, virtual histology, used in the study.",

author = "Eisen, {H. J.}",

note = "Funding Information: The author of this manuscript has a conflict of interest to disclose as described by the American Journal of Transplantation. H.J.E received research grant support from Novartis for a clinical trial of everolimus and from Pfizer for a study of sirolimus in cardiac transplant recipients. Both studies have been completed.",

year = "2012",

month = oct,

doi = "10.1111/j.1600-6143.2012.04240.x",

language = "English (US)",

volume = "12",

pages = "2571--2572",

journal = "American Journal of Transplantation",

issn = "1600-6135",

publisher = "Wiley-Blackwell",

number = "10",

}

TY - JOUR

T1 - A novel definition of cardiac allograft vasculopathy

AU - Eisen, H. J.

N1 - Funding Information: The author of this manuscript has a conflict of interest to disclose as described by the American Journal of Transplantation. H.J.E received research grant support from Novartis for a clinical trial of everolimus and from Pfizer for a study of sirolimus in cardiac transplant recipients. Both studies have been completed.

PY - 2012/10

Y1 - 2012/10

N2 - The author reviews the article by Arora and colleagues (page 2700) and puts into context the observations made regarding the use of everolimus in patients several years out from transplant with established cardiac allograft vasculopathy, as well as the utility of the novel imaging technique, virtual histology, used in the study.

AB - The author reviews the article by Arora and colleagues (page 2700) and puts into context the observations made regarding the use of everolimus in patients several years out from transplant with established cardiac allograft vasculopathy, as well as the utility of the novel imaging technique, virtual histology, used in the study.

UR - http://www.scopus.com/inward/record.url?scp=84867064404&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867064404&partnerID=8YFLogxK

U2 - 10.1111/j.1600-6143.2012.04240.x

DO - 10.1111/j.1600-6143.2012.04240.x

M3 - Editorial

C2 - 23009137

AN - SCOPUS:84867064404

SN - 1600-6135

VL - 12

SP - 2571

EP - 2572

JO - American Journal of Transplantation

JF - American Journal of Transplantation

IS - 10

ER -

A novel definition of cardiac allograft vasculopathy

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this